What is recombinant insulin lispro?

Recombinant insulin lispro is a fast-acting insulin analog.

It has rapid onset of action, short peak time and short duration of action. This makes it better able to simulate physiological insulin secretion and perform well in controlling postprandial blood glucose.

It is often used in diabetic patients for blood glucose management, especially when it is necessary to quickly control postprandial blood glucose elevation. It is administered subcutaneously to facilitate patients 'self-administration.

Generally, it has good safety, but adverse reactions such as hypoglycemia may still occur. During the use process, blood glucose should be closely monitored and the dosage adjusted

according to the specific conditions of patients, blood glucose levels, diet, exercise and other factors to achieve optimal blood glucose control and minimize the occurrence of adverse reactions.

In diabetes treatment, it is often used in combination with long-acting insulin or other hypoglycemic drugs to achieve comprehensive blood glucose control and improve the treatment effect.